Hansen restates revenues after whistleblower claims open can of worms
This article was originally published in Clinica
An internal audit resulting from someone blowing the whistle on an accounting error in one of Hansen Medical’s quarterly results have led the firm to discover improper practices and poor quality control in certain areas of its operations. Consequently, the company has been forced to restate its financial statements for the last two fiscal years.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals